Pseudomembraneous clostridium after autologous bone marrow transplantation

Bone Marrow Transplantation

Volumn 21, Issue 5, 1998, Pages 521-523

  Kavan, P ^a,d   Sochor, M ^a   Nyc, O ^a   Lochmann, O ^a   Koutecky, J ^a   Skala, P J ^b   McClain, L K ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

ABMT; Clostridium difficile; Metronidazole; Pseudomembraneous colitis (PMC); Vancomycin

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; VANCOMYCIN;

ADOLESCENT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BACTERIAL INFECTION; CASE REPORT; CLOSTRIDIUM DIFFICILE; EARLY DIAGNOSIS; EMPYEMA; HEMATOPOIESIS; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; TREATMENT FAILURE;

EID: 0031932985     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701117     Document Type: Article

References (27)

1. Kofsky P, Rosen L, Read J et al. Clostridium difficile - a common and costly colitis. Dis Colon Rectum 1991; 34: 244-248.
2. Marts BC, Longo WE, Wernova IAM et al. Patterns of prognosis of clostridium difficile colitis. Dis Colon Rectum 1994; 37: 837-845.
3. Young LS. Management of infections in leukemia and lymphoma. In: Rubin RH, Young LS (eds). Clinical Approach to Infection in the Compromised Host, 2nd edn. Plenum: New York, 1981, pp 461-506.
4. Bodey GP, Buckley M, Sathe YS et al. Quantitative relationship between circulating leukocytes and infection in patients with leukemia. Ann Intern Med 1966; 64: 328-340.
5. Tsutaoka B, Hansen J, Johnson P et al. Antibiotic-associated pseudomembranous enteritis due to Clostridium difficile. Clin Infect Dis 1994; 18: 982-984.
6. Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992; 15: 573-581.
7. Schuller I, Saha V, Lin L et al. Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit. Arch Dis Child 1995; 72: 219-222.
8. Antoš F. Toxické kolitidy z pohledu chirurga. Rozhl Chir 1995; 74: 155-158.
9. Mandell GL, Douglas BG, Bennett JE. Principles and Practice of Infectious Diseases. Churchill Livingstone: New York, USA, 1995, pp 978-987.
10. Chang TW, Lauerman M, Barlett JG. Cytotoxicity assay in antibiotic-associated colitis. J Infect Dis 1979; 140: 765-770.
11. Wingard JR. Advances in the management of infectious complications after bone marrow transplantation. Bone Marrow Transplant 1990; 6: 371-383.
12. Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum 1995; 38: 350-354.
13. Kelly CK, Pothoulakis C, LaMont JT. Clostridium colitis. New Engl J Med 1994; 330: 257-262.
14. Burden DW. Clostridium difficile: the epidemiology and prevention of hospital acquired infection. Infection 1982; 10: 203-204.
15. Church JM, Fazio VW. The significance of quantitative results of clostridium difficile cultures and toxin assays in patients with diarrhea. Dis Colon Rectum 1985; 28: 765-769.
16. Gerding DN, Olson MM, Peterson LR et al. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-control epidemiologic study. Arch Intern Med 1986; 146: 95-100.
17. Klainer AS. Clindamycin. Med Clin North Am 1987; 71: 1169-1175.
18. Clabot CR, Johnson S, Olson MM et al. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992; 166: 561-567.
19. Brunetto AL, Pearson ADJ, Craft AW et al. Clostridium difficile in an oncology unit. Arch Dis Child 1988; 63: 979-981.
20. McBride M. Antibiotic-associated pseudomembranous enteritis due to Clostridium difficile (letter). Clin Infect Dis 1995; 21: 455.
21. Bender BS, Benner RM, Laughon BE et al. Is Clostridium difficile endemic in chronic care facilities? Lancet 1986; 2: 11-13.
22. Wilcox MH, Spencer RC. Clostridium difficile infection: responses, relapses, re-infections. J Hosp Infect 1992; 22: 85-92.
23. Wilcox HM, Howe R. Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin. J Antimicrob Chemother 1995; 36: 673-679.
24. Talbot RW, Walker RC, Beart TW. Changing epidemiology, diagnosis and treatment of Clostridium difficile toxin associated colitis. Br J Surg 1986; 73: 457-460.
25. Teasley DG, Gerding DN, Olsen MM et al. Prospective randomised trial of metronidazole versus vancomycin for Clostridium difficile associated diarrhoea and colitis. Lancet 1983; 2: 1043-1046.
26. Gerding DN, Olsen MM, Petersen LR et al. Cumulative treatment experience with 607 cases of Clostridium difficile infection. In: Program and Abstract of the Twenty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy. Houston, Texas 1989; 37A: 107.
27. Robert MC, McFarland LV, Mullany P et al. Characterization of the genetic basis of antibiotic resistance in Clostridium difficile. J Antimicrob Chemother 1994; 33: 419-429.